SALT LAKE CITY, April 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Health Catalyst Ignite Spark™, a tailored data and analytics solution built for community health systems, regional hospitals, and multi-site practices.
Smaller community health systems across the U.S. are navigating shrinking margins, policy uncertainty, and rising pressure to deliver more with less. Ignite Spark is our answer—a nimble, flexible, and accessible data and analytics solution purpose-built to meet this moment.
Ignite Spark is designed to be foundational, to seamlessly complement existing systems, and to provide enterprise-grade analytics for teams with lean resources.
"Early last year, we launched Health Catalyst Ignite™ with the commitment to meet health systems where they are—and the development of Ignite Spark affirms our dedication to that," said Dan Burton, CEO of Health Catalyst. "Over the past year, we have engaged in meaningful discussions with CIOs, CFOs, and senior clinical leaders at regional health systems. A recurring theme in these conversations has been the challenge of managing multiple vendors, navigating overwhelming volumes of data, and operating with limited time, budget, and personnel to extract meaningful insights. Recognizing this pervasive, pressing need, we developed a tailored solution for healthcare teams with ambitious goals but lean resources."
Ignite Spark ingests and normalizes data from multiple sources, centralizes governance, and empowers frontline teams with self-service access to actionable insights—all while reducing IT burden and unnecessary cost.
Ignite Spark breaks down the cost, access, and expertise barrier; through this streamlined solution, regional hospital networks, primary care networks, urgent care centers, and specialty practices can drive data-informed clinical, revenue performance, and cost control improvement.
"For too long, community hospitals have been underserved by traditional data platforms—Ignite Spark was built to change that," said Dave Ross, Chief Technology and Product Officer at Health Catalyst. "It brings the full power of enterprise analytics—right-sized, simplified, and accessible—to organizations that have been asked to do more with less without the tools to do it."
About Health Catalyst
Health Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,000 organizations worldwide rely on Health Catalyst's offerings, including our cloud-based technology ecosystem Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, measurable, data-informed healthcare improvement and innovation.
Media Contact:
Kathryn Mykleseth
PR and Communications Director
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Relations Contact:
Jack Knight
Vice President, Investor Relations
+1 (855) 309-6800
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$3.70 |
Daily Change: | -0.14 -3.65 |
Daily Volume: | 400,655 |
Market Cap: | US$225.140M |
February 26, 2025 November 06, 2024 November 06, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load